About a year after investing in Vigil Neuroscience Inc., Sanofi is now acquiring the Watertown biotech and its treatment in ...

GSK Plc won US approval for its drug to treat a deadly lung disease, ramping up competition with rival Sanofi.

Sanofi relocated 2,000 employees to a new $130M Morristown flagship office at M Station West in May, leaving Bridgewater.

Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...

Sanofi spent $130 million outfitting the 260,000 square feet it now occupies for 2,000 employees at M Station West.

Global healthcare company Sanofi yesterday formally opened its new flagship US offices at M Station West in Morristown.

The approval tees GSK up to challenge Sanofi and Regeneron, which in September 2024 won the first biologic approval for COPD ...

Sanofi to acquire clinical-stage biotechnology company, Vigil Neuroscience for $470 million: Paris Friday, May 23, 2025, 11:00 Hrs [IST] Sanofi, an innovative global healthcare co ...

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

Novo Nordisk NVO announced the surprise resignation of its chief executive officer (CEO), Lars Fruergaard Jørgensen. Sanofi ...

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood could help clinicians more quickly identify and determine if pancreatic cancer ...

3 Year-5.75%-0.86% 50.10% 53.06% ...